INOZYME PHARMA, INC. Stock-Based Compensation
INOZYME PHARMA, INC. reported Stock-Based Compensation of $1.86 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-05-14
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $1.86M, a 9.82% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $1.97M, a 17.81% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $2.13M, a 27.15% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2024-06-30 was $2.16M, a 34.81% increase year-over-year.
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $7.95M, a 12.90% increase from fiscal 2023.
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $7.04M, a 8.28% decline from fiscal 2022.
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $7.67M, a 7.09% increase from fiscal 2021.
- INOZYME PHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $7.16M, a 210.40% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-14 | $3.83M derived: sum of 2 quarters · filed 2025-05-14 | $5.95M derived: sum of 3 quarters · filed 2025-05-14 | $8.11M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $4.10M derived: sum of 2 quarters · filed 2025-03-10 | $6.25M derived: sum of 3 quarters · filed 2025-03-10 | $7.95M 10-K · filed 2025-03-10 |
| 2024-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $4.28M derived: sum of 2 quarters · filed 2024-11-05 | $5.97M 10-Q · filed 2024-11-05 | $7.65M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.85M 10-Q · filed 2024-08-06 | $5.52M derived: sum of 3 quarters · filed 2025-05-14 | $7.19M derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-14 | $3.36M derived: sum of 2 quarters · filed 2025-05-14 | $5.04M derived: sum of 3 quarters · filed 2025-05-14 | $6.64M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $3.35M derived: sum of 2 quarters · filed 2025-03-10 | $4.95M derived: sum of 3 quarters · filed 2025-03-10 | $7.04M 10-K · filed 2025-03-10 |
| 2023-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $3.27M derived: sum of 2 quarters · filed 2024-11-05 | $5.36M 10-Q · filed 2024-11-05 | $7.25M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $3.69M 10-Q · filed 2024-08-06 | $5.58M derived: sum of 3 quarters · filed 2024-08-06 | $7.43M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $2.09M 10-Q · filed 2024-05-07 | $3.98M derived: sum of 2 quarters · filed 2024-05-07 | $5.83M derived: sum of 3 quarters · filed 2024-05-07 | $8.01M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $3.73M derived: sum of 2 quarters · filed 2024-03-12 | $5.92M derived: sum of 3 quarters · filed 2024-03-12 | $7.67M 10-K · filed 2024-03-12 |
| 2022-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.03M derived: sum of 2 quarters · filed 2023-11-07 | $5.79M 10-Q · filed 2023-11-07 | $7.81M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $3.94M 10-Q · filed 2023-08-08 | $5.96M derived: sum of 3 quarters · filed 2023-08-08 | $7.71M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.75M 10-Q · filed 2023-05-09 | $3.77M derived: sum of 2 quarters · filed 2023-05-09 | $5.53M derived: sum of 3 quarters · filed 2023-05-09 | $7.34M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.77M derived: sum of 2 quarters · filed 2023-03-22 | $5.59M derived: sum of 3 quarters · filed 2023-03-22 | $7.16M 10-K · filed 2023-03-22 |
| 2021-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.56M derived: sum of 2 quarters · filed 2022-11-10 | $5.14M 10-Q · filed 2022-11-10 | $6.42M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $3.39M 10-Q · filed 2022-08-15 | $4.66M derived: sum of 3 quarters · filed 2022-08-15 | $5.45M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-10 | $2.85M derived: sum of 2 quarters · filed 2022-05-10 | $3.64M derived: sum of 3 quarters · filed 2022-05-10 | $3.76M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.06M derived: sum of 2 quarters · filed 2022-03-15 | $2.18M derived: sum of 3 quarters · filed 2022-03-15 | $2.31M 10-K · filed 2022-03-15 |
| 2020-09-30 | $786.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $906.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.03M 10-Q · filed 2021-11-09 | $1.15M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $249.00K 10-Q · filed 2021-08-11 | $362.00K derived: sum of 3 quarters · filed 2021-08-11 | $469.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $129.00K 10-Q · filed 2021-05-12 | $242.00K derived: sum of 2 quarters · filed 2021-05-12 | $349.00K derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $220.00K derived: sum of 2 quarters · filed 2021-03-25 | $301.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $188.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $81.00K 10-Q · filed 2020-09-03 |